TrialJournal of bone and mineral metabolism2022

Strontium-89 plus zoledronic acid versus zoledronic acid for patients with painful bone metastatic breast cancer.

Kimito Yamada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.